Literature DB >> 30801189

In Silico Exploration of the Molecular Mechanism of Cassane Diterpenoids on Anti-inflammatory and Immunomodulatory Activity.

Ying Wang1,2, Baichun Hu1,3, Yusheng Peng2, Xin Xiong1,2, Wenhua Jing1,2, Jian Wang1,3, Huiyuan Gao1,2.   

Abstract

Cassane diterpenoids (CAs), recognized as main constituents of many medical plants of the genus Caesalpinia, exhibit diverse bioactivities, including anti-inflammatory and immunomodulatory activity, and also showed a therapeutic effect on rheumatoid arthritis (RA) according to previous work, including ours. In this study, 102 CA compounds were selected to explore the possible molecular mechanism of this class of natural products on anti-inflammatory and immunomodulatory activity using RA as a disease model through a series of in silico methods: chemical-similarity-based target prediction, molecular docking, and molecular dynamics (MD) simulation. As a consequence, four signaling pathways (TCR signaling pathway, TLR signaling pathway, VEGF signaling pathway, and osteoclast differentiation pathway) by which CAs exert their effect on inflammation and immunomodulation were identified. Furthermore, the binding modes of CAs complexing with several crucial targets, which were picked out by credible docking results and took part in these signaling pathways, were explored by MD simulations. This is the first time that the molecular mechanism of the anti-RA activity of natural CAs has been investigated with in silico methods, and these findings might explain the activity of CAs on anti-inflammation and immunomodulation, which could supply a valuable reference for drug design research on CAs.

Entities:  

Year:  2019        PMID: 30801189     DOI: 10.1021/acs.jcim.8b00862

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  2 in total

1.  Design, Synthesis and Molecular Docking Analysis of Flavonoid Derivatives as Potential Telomerase Inhibitors.

Authors:  Zhan-Fang Fan; Sai-Tim Ho; Rui Wen; Ya Fu; Lei Zhang; Jian Wang; Chun Hu; Pang-Chui Shaw; Yang Liu; Mao-Sheng Cheng
Journal:  Molecules       Date:  2019-09-01       Impact factor: 4.411

2.  Carrier-free supramolecular nanoassemblies of pure LSD1 inhibitor for effective anti-tumor therapy.

Authors:  Boao Li; Xiangyu Zhang; Jibin Li
Journal:  Front Chem       Date:  2022-09-30       Impact factor: 5.545

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.